{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:31:47Z","timestamp":1791210707500,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T00:00:00Z","timestamp":1393804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.addr.2014.02.010","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T03:45:39Z","timestamp":1393559139000},"page":"162-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Gene and cell therapy for children \u2014 New medicines, new challenges?"],"prefix":"10.1016","volume":"73","author":[{"given":"Karen F.","family":"Buckland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bobby Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2014.02.010_bb0005","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.2337\/db12-0033","article-title":"Clinical islet xenotransplantation: how close are we?","volume":"61","author":"van der Windt","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2014.02.010_bb0010","series-title":"UK Clinical Trials Database","author":"Cell Therapy Catapult","year":"2013"},{"key":"10.1016\/j.addr.2014.02.010_bb0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ICU.0b013e328329b5f2","article-title":"Stem-cell therapy in retinal disease","volume":"20","author":"Baker","year":"2009","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.addr.2014.02.010_bb0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(12)60028-2","article-title":"Embryonic stem cell trials for macular degeneration: a preliminary report","volume":"379","author":"Schwartz","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2014.02.010_bb0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMoa0905955","article-title":"Limbal stem-cell therapy and long-term corneal regeneration","volume":"363","author":"Rama","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2014.02.010_bb0040","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1242\/dev.092270","article-title":"Stem cells in retinal regeneration: past, present and future","volume":"140","author":"Ramsden","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.addr.2014.02.010_bb0050","first-page":"175","article-title":"Transplantation of intact pancreatic islets in rats","volume":"72","author":"Ballinger","year":"1972","journal-title":"Surgery"},{"key":"10.1016\/j.addr.2014.02.010_bb0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2337\/diab.39.4.515","article-title":"Insulin independence after islet transplantation into type I diabetic patient","volume":"39","author":"Scharp","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2014.02.010_bb0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2014.02.010_bb0070","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/CS20050342","article-title":"Current status of pancreatic islet transplantation","volume":"110","author":"Merani","year":"2006","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.addr.2014.02.010_bb0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3727\/000000007783465064","article-title":"Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients","volume":"16","author":"Torrente","year":"2007","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2014.02.010_bb0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1479-5876-9-65","article-title":"Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with hereditary ataxia","volume":"9","author":"Yang","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.addr.2014.02.010_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcyt.2012.10.007","article-title":"Optimization of methodology for production of CD25\/CD71 allodepleted donor T cells for clinical use","volume":"15","author":"Albon","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.addr.2014.02.010_bb0100","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2006-02-001909","article-title":"Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation","volume":"108","author":"Amrolia","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.addr.2014.02.010_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/erm.12.133","article-title":"Assessment of regulatory T-cell function in forthcoming clinical trials of cell therapy","volume":"13","author":"Canavan","year":"2013","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.addr.2014.02.010_bb0110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein\u2013Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Heslop","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2014.02.010_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1358.013","article-title":"T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients","volume":"1062","author":"Leen","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2014.02.010_bb0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.humimm.2004.02.015","article-title":"Gene transfer for activation of CMV specific T cells","volume":"65","author":"Andre-Schmutz","year":"2004","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.addr.2014.02.010_bb0125","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2014.02.010_bb0130","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/10430340252899028","article-title":"Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp 65 or against adenovirus and EpsteinBarr virus EBNA3C protein: a novel approach for immunotherapy","volume":"13","author":"Hamel","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2014.02.010_bb0135","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.beha.2011.06.001","article-title":"Novel strategies for adoptive therapy following HLA disparate transplants","volume":"24","author":"O'Reilly","year":"2011","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.addr.2014.02.010_bb0140","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.addr.2014.02.010_bb0150","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/adc.2006.108787","article-title":"Update on clinical gene therapy in childhood","volume":"92","author":"Qasim","year":"2007","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.addr.2014.02.010_bb0155","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1089\/hum.2012.116","article-title":"Gene therapy for primary immunodeficiencies","volume":"23","author":"Rivat","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2014.02.010_bb0160","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2174\/156652308786848049","article-title":"Clinical application of lentiviral vectors \u2014 concepts and practice","volume":"8","author":"Schambach","year":"2008","journal-title":"Curr. Gene. Ther."},{"key":"10.1016\/j.addr.2014.02.010_bb0165","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/mt.2011.309","article-title":"Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity","volume":"20","author":"Suerth","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2014.02.010_bb0170","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/mt.2012.249","article-title":"Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing","volume":"21","author":"Kaufmann","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2014.02.010_bb0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/15513815.2012.754527","article-title":"The immune environment of paediatric solid malignancies: evidence from an immunohistochemical study of clinical cases","volume":"32","author":"Apps","year":"2013","journal-title":"Fetal Pediatr. Pathol."},{"key":"10.1016\/j.addr.2014.02.010_bb0185","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2","volume":"18","author":"Morgan","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2014.02.010_bb0190","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/mt.2010.42","article-title":"Safer CARS","volume":"18","author":"Heslop","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2014.02.010_bb0195","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mt.2010.31","article-title":"Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial","volume":"18","author":"Brentjens","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2014.02.010_bb0205","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2014.02.010_bb0210","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/mt.2010.201","article-title":"Ex-vivo gene therapy restores LEKTI activity and corrects the architecture of Netherton syndrome-derived skin grafts","volume":"19","author":"Di","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2014.02.010_bb0215","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/hum.2013.063","article-title":"From mutation identification to therapy: discovery and origins of the first approved gene therapy in the Western world","volume":"24","author":"Kastelein","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2014.02.010_bb0225","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jgm.1028","article-title":"Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses","volume":"9","author":"Aronovich","year":"2007","journal-title":"J. Gene. Med."},{"key":"10.1016\/j.addr.2014.02.010_bb0230","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jgm.885","article-title":"Immune responses to AAV in a phase I study for Canavan disease","volume":"8","author":"McPhee","year":"2006","journal-title":"J. Gene. Med."},{"key":"10.1016\/j.addr.2014.02.010_bb0235","doi-asserted-by":"crossref","first-page":"161ra152","DOI":"10.1126\/scitranslmed.3004190","article-title":"Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy","volume":"4","author":"Wykes","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2014.02.010_bb0245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrd3918","article-title":"Gene therapy: suppressing seizures","volume":"12","author":"Faruqi","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2014.02.010_bb0255","series-title":"Gene and Cell Therapies for Inherited Sight Loss","author":"UCL institute of Ophthalmology","year":"2013"},{"key":"10.1016\/j.addr.2014.02.010_bb0265","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2014.02.010_bb0275","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MOH.0b013e328363c1a1","article-title":"Gene therapy for hemophilia: advancing beyond the first clinical success","volume":"20","author":"Monahan","year":"2013","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.addr.2014.02.010_bb0285","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2014.02.010_bb0290","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/thoraxjnl-2013-203309","article-title":"A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis","volume":"68","author":"Alton","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.addr.2014.02.010_rf0200","doi-asserted-by":"crossref","DOI":"10.1111\/febs.12178","article-title":"Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies","volume":"280","author":"Benedetti","year":"2013","journal-title":"FEBS J."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X14000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X14000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T04:59:51Z","timestamp":1538801991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X14000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":44,"alternative-id":["S0169409X14000325"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2014.02.010","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene and cell therapy for children \u2014 New medicines, new challenges?","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2014.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}